Brussels, 13/04/2004 (Agence Europe) - In a report published on 7 April the WTO Appellate Body reversed the finding of a WTO panel in December 2003 -and rejected India's claim that WTO rules do not allow to differentiate between developing countries. India had challenged the EU's system of trade preferences for seriously drug-affected countries (so-called GSP drug regime). In this system, twelve developing countries (11 Latin American countries and Pakistan) benefit from additional...